Yutaka Tsukada

2.8k total citations
97 papers, 2.3k citations indexed

About

Yutaka Tsukada is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yutaka Tsukada has authored 97 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 20 papers in Surgery and 13 papers in Oncology. Recurrent topics in Yutaka Tsukada's work include Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Toxin Mechanisms and Immunotoxins (9 papers). Yutaka Tsukada is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Toxin Mechanisms and Immunotoxins (9 papers). Yutaka Tsukada collaborates with scholars based in Japan, United States and Israel. Yutaka Tsukada's co-authors include Hidematsu Hirai, Nozomu Hibi, Henry C. Pitot, Kiyoshi Ohkawa, W. Lance Richards, Takashi Natori, Miki Aizawa, Hiroshi Ishikura, Naoyuki Taniguchi and Yuichiro Fukasawa and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yutaka Tsukada

96 papers receiving 2.1k citations

Peers

Countries citing papers authored by Yutaka Tsukada

Since Specialization

Citations

This map shows the geographic impact of Yutaka Tsukada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Tsukada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Tsukada more than expected).

Fields of papers citing papers by Yutaka Tsukada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Tsukada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Tsukada. The network helps show where Yutaka Tsukada may publish in the future.

Co-authorship network of co-authors of Yutaka Tsukada

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Tsukada. A scholar is included among the top collaborators of Yutaka Tsukada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Tsukada. Yutaka Tsukada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2010 ·Journal of The Japan Institute of Electronics Packaging ·Yutaka Tsukada	2
2	Molecular Staging of Prostate Cancer: Comparison of Nested Reverse Transcription Polymerase Chain Reaction Assay Using Prostate Specific Antigen Versus Prostate Specific Membrane Antigen as Primer 1998 ·International Journal of Urology ·Takatsugu Okegawa, (unknown), Ryoji Morita, Kikuo Nutahara, Yutaka Tsukada, (unknown)	13
3	Bisecting GlcNAc Structures Act as Negative Sorting Signals for Cell Surface Glycoproteins in Forskolin-treated Rat Hepatoma Cells 1997 ·Journal of Biological Chemistry ·Ahmed Sultan, Eiji Miyoshi, Yoshito Ihara, Atsushi Nishikawa, Yutaka Tsukada, Naoyuki Taniguchi	27
4	Novel Thyrotropin (TSH)—TSH Antibody Complex in a Healthy Woman and Her Neonates 1995 ·Thyroid ·Haruo Tamaki, Keiko Takeoka, Isao Nishi, (unknown), Yutaka Tsukada, Nobuyuki Amino	13
5	Characterization of tumor-associated antigen (2H6 antigen) defined by monoclonal antibody 2H6 1994 ·Clinica Chimica Acta ·(unknown), Takahiro Kubota, Yutaka Tsukada, Yutaka Karasawa	1
6	Inhibition of the Nerve Growth Factor-Induced Neurite Outgrowth by Specific Tyrosine Kinase and Phospholipase Inhibitors. 1994 ·Biological and Pharmaceutical Bulletin ·Yutaka Tsukada, Kenzo Chiba, Masakazu Yamazaki, (unknown)	18
7	Renal cell carcinoma producing α‐fetoprotein (AFP) with a unique lectins‐affinity profile 1994 ·Journal of Surgical Oncology ·Toshinari Minamoto, Masanobu Kitagawa, Naoko Amano, Yutaka Tsukada, Tatsuo Hirose, Masayoshi Mai	10
8	Evaluation of tumor-associated antigen (2H6 antigen) in detecting early stages of gastric cancer 1994 ·Clinica Chimica Acta ·(unknown), Yutaka Tsukada, Yutaka Karasawa	5
9	Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro 1993 ·British Journal of Cancer ·Kiyoshi Ohkawa, Taku Hatano, Yutaka Tsukada, Makoto Matsuda	17
10	Production of chromogranin A and B derived peptides in human small cell lung carcinoma cell lines 1992 ·European Journal of Cancer ·Haruo Iguchi, (unknown), (unknown), Yutaka Tsukada	13
11	PAF acetylhydrolase activities in human systemic lupus erythematosus and lupus-prone mice 1992 ·Clinica Chimica Acta ·Masaharu Matsuzaki, (unknown), (unknown), Yutaka Tsukada, Hiroshi Kayahara, (unknown)	6
12	Growth of a human yolk sac tumor cell line with yolk sac-derived functions in selenium-supplemented chemically defined synthetic medium 1992 ·In Vitro Cellular & Developmental Biology - Animal ·Kiyoshi Ohkawa, (unknown), (unknown), (unknown), Kyosuke Yamada, Makoto Matsuda, Koji Takada, Yutaka Tsukada	4
13	Clear cell carcinoma of the human ovary synthesizes and secretes a transferrin with microheterogeneity of lectin affinity 1990 ·FEBS Letters ·Kiyoshi Ohkawa, Koji Takada, (unknown), Takashi Hatano, Yutaka Tsukada, Makoto Matsuda	9
14	Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation? 1990 ·Cancer ·Akishi Ooi, Isao Nakanishi, Naoko Sakamoto, Yutaka Tsukada, Yutaka Takahashi, Toshinari Minamoto, Masayoshi Mai	73
15	Overcoming effect of antibody against rat alpha‐fetoprotein (AFP) on the growth of daunorubicin‐resistant mutant rat ascites hepatoma cell line AH66 1989 ·International Journal of Cancer ·Kiyoshi Ohkawa, Yutaka Tsukada, Toshio Abe, Koji Takada, Nozomu Hibi	5
16	The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity 1988 ·British Journal of Cancer ·Kiyoshi Ohkawa, Yutaka Tsukada, (unknown), (unknown), Y. Terashima	43
17	A comparison of the localization of higher cortical functions in crossed dextral aphasia and sinistral aphasia. 1982 ·Shitsugoshō kenkyū ·(unknown), (unknown), (unknown), Yutaka Tsukada, (unknown)	10
18	Alpha-fetoprotein and albumin produced by subclonal cell population of the ascites hepatoma AH-66 in vitro. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), Yutaka Tsukada, Hidematsu Hirai	5
19	Effect of cyclic AMP and related substances on the production of alpha-fetoprotein by ascites hepatoma AH-66 cells in culture. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), Makoto Umeda, Hidematsu Hirai, Yutaka Tsukada	2
20	α‐FETOPROTEIN SYNTHESIS IN CULTURED CELLS: STUDIES ON YOSHIDA SARCOMA AND ASCITES HEPATOMA IN VITRO 1975 ·Annals of the New York Academy of Sciences ·(unknown), (unknown), Yutaka Tsukada	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact